The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of March. The chart below provides highlights of key monograph updates made this month (not an inclusive list).

Click on the name of the drugs to view the full monographs on eMPR.com.

Key: D=Dosing, IND=Indication, ITX=Interactions, CI=Contraindications,
W/P=Warnings/Precautions, ADR=Adverse Reactions,
HS=How Supplied, MFR=Manufacturer Change

DRUG NAME UPDATES
(Click on drug name to go to MPR monograph.) IND D CON W/P ITX ADR HS MFR
ALOPRIM (Allopurinol [as sodium])   X X X X X    
ARTESUNATE FOR INJECTION (Artesunate)       X   X  
ASTEPRO ALLERGY (Azelastine HCl) X X   X X X  
CELEXA (Citalopram [as HBr])   X     X    
CONRAY (Iothalamate meglumine) X X   X     X  
FINTEPLA (Fenfluramine) X X   X X  
   
KAZANO (Alogliptin, metformin [as HCl])   X X X        
OZEMPIC (Semaglutide)   X   X   X    
RISPERDAL (Risperidone)   X
  X      
XIGDUO XR (Dapagliflozin, metformin HCl ext-rel) X X   X X X    
Review more drug monograph updates